ReP USP - Resultado da busca

Artigo de periodico
Scientific research on bioethanol in Brazil: history and prospects for sustainable biofuel (2024)
Grandis, Adriana ; Fortirer, Janaina da Silva ; Pagliuso, Débora ; Buckeridge, Marcos
Source: Sustainability. Unidades: BIOTECNOLOGIA, IB, BIOINFORMÁTICA
Subjects: BIOCOMBUSTÍVEIS, ETANOL, BIOMASSA, SUSTENTABILIDADE, BIOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRANDIS, Adriana et al. Scientific research on bioethanol in Brazil: history and prospects for sustainable biofuel. Sustainability, 2024Tradução . . Disponível em: https://doi.org/10.3390/su16104167. Acesso em: 05 nov. 2024.
APA
Grandis, A., Fortirer, J. da S., Pagliuso, D., & Buckeridge, M. (2024). Scientific research on bioethanol in Brazil: history and prospects for sustainable biofuel. Sustainability. doi:10.3390/su16104167
NLM
Grandis A, Fortirer J da S, Pagliuso D, Buckeridge M. Scientific research on bioethanol in Brazil: history and prospects for sustainable biofuel [Internet]. Sustainability. 2024 ;[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/su16104167
Vancouver
Grandis A, Fortirer J da S, Pagliuso D, Buckeridge M. Scientific research on bioethanol in Brazil: history and prospects for sustainable biofuel [Internet]. Sustainability. 2024 ;[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/su16104167
Artigo de periodico
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 (2024)
Santos, Yasmin Silva ; Gamon, Thaís Helena Martins ; Azevedo, Marcela Santiago Pacheco de ; Bielavsky, Mônica ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Souza, Edmarcia Elisa de ; Luvizotto, Maria Cecília Rui ; Ackerman, Hans Christian; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina ; Wrenger, Carsten ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias
Source: Frontiers in Pharmacology. Unidades: FCF, ICB, BIOTECNOLOGIA
Subjects: PARASITOLOGIA, MICROBIOLOGIA, COVID-19, INIBIDORES DE ENZIMAS, DOENÇAS RESPIRATÓRIAS, ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, ANTIVIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin Silva et al. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1414406. Acesso em: 05 nov. 2024.
APA
Santos, Y. S., Gamon, T. H. M., Azevedo, M. S. P. de, Bielavsky, M., Darido, M. L. G., Oliveira, D. B. L. de, et al. (2024). Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1414406
NLM
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Vancouver
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Artigo de periodico
iPSC-derived cells for whole liver bioengineering (2024)
Silva, Kayque Alves Telles ; Pacheco, Lara ; Chianca, Fernanda; Komatsu, Sabrina ; Chiovatto, Caroline; Zatz, Mayana ; Goulart, Ernesto
Source: Frontiers in Bioengineering and Biotechnology. Unidades: IB, BIOTECNOLOGIA
Subjects: FÍGADO, BIOENGENHARIA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Kayque Alves Telles et al. iPSC-derived cells for whole liver bioengineering. Frontiers in Bioengineering and Biotechnology, v. 12, 2024Tradução . . Disponível em: https://doi.org/10.3389/fbioe.2024.1338762. Acesso em: 05 nov. 2024.
APA
Silva, K. A. T., Pacheco, L., Chianca, F., Komatsu, S., Chiovatto, C., Zatz, M., & Goulart, E. (2024). iPSC-derived cells for whole liver bioengineering. Frontiers in Bioengineering and Biotechnology, 12. doi:10.3389/fbioe.2024.1338762
NLM
Silva KAT, Pacheco L, Chianca F, Komatsu S, Chiovatto C, Zatz M, Goulart E. iPSC-derived cells for whole liver bioengineering [Internet]. Frontiers in Bioengineering and Biotechnology. 2024 ; 12[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fbioe.2024.1338762
Vancouver
Silva KAT, Pacheco L, Chianca F, Komatsu S, Chiovatto C, Zatz M, Goulart E. iPSC-derived cells for whole liver bioengineering [Internet]. Frontiers in Bioengineering and Biotechnology. 2024 ; 12[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fbioe.2024.1338762
Artigo de periodico
Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation (2023)
Celestino, Gabriela Gomes; Amarante, Marla Karine ; Vespero, Eliana Carolina ; Tavares, Eliandro Reis ; Yamauchi, Lucy Megumi ; Candido, Érika Donizetti ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Ogatta, Sueli Fumie Yamada
Source: Pathogens. Unidades: ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, TROMBOSE, COVID-19, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, MANIFESTAÇÕES CUTÂNEAS, FERIMENTOS E LESÕES, GENOMAS, SEQUENCIAMENTO GENÉTICO, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CELESTINO, Gabriela Gomes et al. Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation. Pathogens, v. 12, n. 3, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.3390/pathogens12030438. Acesso em: 05 nov. 2024.
APA
Celestino, G. G., Amarante, M. K., Vespero, E. C., Tavares, E. R., Yamauchi, L. M., Candido, É. D., et al. (2023). Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation. Pathogens, 12( 3), 1-11. doi:10.3390/pathogens12030438
NLM
Celestino GG, Amarante MK, Vespero EC, Tavares ER, Yamauchi LM, Candido ÉD, Oliveira DBL de, Durigon EL, Ogatta SFY. Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation [Internet]. Pathogens. 2023 ; 12( 3): 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/pathogens12030438
Vancouver
Celestino GG, Amarante MK, Vespero EC, Tavares ER, Yamauchi LM, Candido ÉD, Oliveira DBL de, Durigon EL, Ogatta SFY. Dermatological manifestations in COVID-19: a case study of SARS-CoV-2 infection in a genetic thrombophilic patient with Mthfr mutation [Internet]. Pathogens. 2023 ; 12( 3): 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/pathogens12030438
Artigo de periodico
Effect of monocerin, a fungal secondary metabolite, on endothelial cells (2023)
Gomes, Tainah Colombo ; Conrado, Rafael ; Oliveira, Rodrigo Cardoso de ; Selari, Priscila Jane Romano Gonçalves ; Melo, Itamar Soares de ; Maria, Durvanei Augusto ; Souza, Ana Olívia De ; Araújo, Welington Luiz de
Source: Toxins. Unidades: ICB, BIOTECNOLOGIA, FCF
Subjects: MICROBIOLOGIA, INTERAÇÃO CELULAR, CÉLULAS ENDOTELIAIS, PROLIFERAÇÃO CELULAR, METABOLISMO SECUNDÁRIO, METABÓLITOS SECUNDÁRIOS, LACTATOS, ESTRESSE OXIDATIVO, DANO AO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Tainah Colombo et al. Effect of monocerin, a fungal secondary metabolite, on endothelial cells. Toxins, v. 15, n. 5, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/toxins15050344. Acesso em: 05 nov. 2024.
APA
Gomes, T. C., Conrado, R., Oliveira, R. C. de, Selari, P. J. R. G., Melo, I. S. de, Maria, D. A., et al. (2023). Effect of monocerin, a fungal secondary metabolite, on endothelial cells. Toxins, 15( 5), 1-18. doi:10.3390/toxins15050344
NLM
Gomes TC, Conrado R, Oliveira RC de, Selari PJRG, Melo IS de, Maria DA, Souza AOD, Araújo WL de. Effect of monocerin, a fungal secondary metabolite, on endothelial cells [Internet]. Toxins. 2023 ; 15( 5): 1-18.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/toxins15050344
Vancouver
Gomes TC, Conrado R, Oliveira RC de, Selari PJRG, Melo IS de, Maria DA, Souza AOD, Araújo WL de. Effect of monocerin, a fungal secondary metabolite, on endothelial cells [Internet]. Toxins. 2023 ; 15( 5): 1-18.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/toxins15050344
Artigo de periodico
Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19 (2023)
Silva, Camila Fonseca Amorim da ; Camalhonte, Samanta Omae ; Almeida, Michell Oliveira ; Araujo, Sheila Cruz ; Sannomiya, Miriam ; Lago, João Henrique Ghilardi ; Honorio, Kathia Maria
Source: Drugs and Drug Candidates. Unidades: EACH, BIOTECNOLOGIA, IQSC
Assunto: COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Camila Fonseca Amorim da et al. Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19. Drugs and Drug Candidates, v. 2, n. 2, p. 433-458, 2023Tradução . . Disponível em: https://doi.org/10.3390/ddc2020022. Acesso em: 05 nov. 2024.
APA
Silva, C. F. A. da, Camalhonte, S. O., Almeida, M. O., Araujo, S. C., Sannomiya, M., Lago, J. H. G., & Honorio, K. M. (2023). Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19. Drugs and Drug Candidates, 2( 2), 433-458. doi:10.3390/ddc2020022
NLM
Silva CFA da, Camalhonte SO, Almeida MO, Araujo SC, Sannomiya M, Lago JHG, Honorio KM. Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19 [Internet]. Drugs and Drug Candidates. 2023 ; 2( 2): 433-458.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/ddc2020022
Vancouver
Silva CFA da, Camalhonte SO, Almeida MO, Araujo SC, Sannomiya M, Lago JHG, Honorio KM. Effect of the N501Y mutation on ligands complexed with SARS-CoV-2 RBD: insights on potential drug candidates for COVID-19 [Internet]. Drugs and Drug Candidates. 2023 ; 2( 2): 433-458.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/ddc2020022
Artigo de periodico
Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV (2023)
Nardy, Ariane ; Camargo, Camila Tussato Soares ; Oliveira, Yasmim Faustina Castro de ; Silva, Fernanda Cristina da; Almeida, Millena Soares de; Monteiro, Fernanda Rodrigues ; Silva, Brenda Rodrigues ; Amaral, Jônatas Bussador do ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Scagion, Guilherme Pereira ; Chalup, Vanessa Nascimento ; Candido, Érika Donizetti ; Aguiar, Andressa Simões ; Novo, Neil Ferreira ; Shio, Marina Tiemi ; França, Carolina Nunes ; Nali, Luiz Henrique da Silva ; Bachi, André Luis Lacerda
Source: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, POLIMORFISMO, CITOMEGALOVIRUS, IMUNOGLOBULINAS, SURTOS DE DOENÇAS, COVID-19, INTERFERONS, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDY, Ariane et al. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, v. 11, n. 2, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11020480. Acesso em: 05 nov. 2024.
APA
Nardy, A., Camargo, C. T. S., Oliveira, Y. F. C. de, Silva, F. C. da, Almeida, M. S. de, Monteiro, F. R., et al. (2023). Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, 11( 2), 1-18. doi:10.3390/vaccines11020480
NLM
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/vaccines11020480
Vancouver
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/vaccines11020480
Artigo de periodico
Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection (2023)
Russo, Momtchilo ; Corrêa, Maria Cássia Mendes ; Lins, Bruna Bezerra ; Kersten, Victor; Pernambuco Filho, Paulo Castanho de Almeida ; Martins, Toni Ricardo ; Mendoza, Tânia Regina Tozetto ; Boas, Lucy Santos Vilas ; Gomes, Brisa Moreira; Dati, Lívia Mendonça Munhoz ; Duarte Neto, Amaro Nunes ; Reigado, Gustavo Roncoli ; Frederico, Ana Beatriz T. ; Cunha, Danielle R. de A. de Brito e ; Paula, Anderson Vicente de ; Silva, José Igor Gomes da ; Vasconcelos, Carlos Frederico Alves de ; Alcalde, Felipe Santiago Chambergo ; Dantas, Viviane Abreu Nunes Cerqueira ; Bom, Ana Paula Dinis Ano; Castilho, Leda R. ; Martins, Rodrigo A. P.; Hirata, Mario Hiroyuki ; Mirotti, Luciana
Source: Vaccines. Unidades: ICB, FM, EACH, FCF, BIOTECNOLOGIA
Subjects: IMUNIDADE, CAMUNDONGOS, LIPOSSOMOS, VACINAS VIRAIS, INFECÇÕES POR CORONAVIRUS, COVID-19, ADENOVÍRUS, PROTEÍNAS RECOMBINANTES, GLICOPROTEÍNAS, CAMUNDONGOS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Momtchilo et al. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection. Vaccines, v. No 2023, n. 11, p. 01-17, 2023Tradução . . Disponível em: http://dx.doi.org/10.3390/vaccines11111732. Acesso em: 05 nov. 2024.
APA
Russo, M., Corrêa, M. C. M., Lins, B. B., Kersten, V., Pernambuco Filho, P. C. de A., Martins, T. R., et al. (2023). Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection. Vaccines, No 2023( 11), 01-17. doi:10.3390/vaccines11111732
NLM
Russo M, Corrêa MCM, Lins BB, Kersten V, Pernambuco Filho PC de A, Martins TR, Mendoza TRT, Boas LSV, Gomes BM, Dati LMM, Duarte Neto AN, Reigado GR, Frederico ABT, Cunha DR de A de B e, Paula AV de, Silva JIG da, Vasconcelos CFA de, Alcalde FSC, Dantas VANC, Bom APDA, Castilho LR, Martins RAP, Hirata MH, Mirotti L. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection [Internet]. Vaccines. 2023 ; No 2023( 11): 01-17.[citado 2024 nov. 05 ] Available from: http://dx.doi.org/10.3390/vaccines11111732
Vancouver
Russo M, Corrêa MCM, Lins BB, Kersten V, Pernambuco Filho PC de A, Martins TR, Mendoza TRT, Boas LSV, Gomes BM, Dati LMM, Duarte Neto AN, Reigado GR, Frederico ABT, Cunha DR de A de B e, Paula AV de, Silva JIG da, Vasconcelos CFA de, Alcalde FSC, Dantas VANC, Bom APDA, Castilho LR, Martins RAP, Hirata MH, Mirotti L. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection [Internet]. Vaccines. 2023 ; No 2023( 11): 01-17.[citado 2024 nov. 05 ] Available from: http://dx.doi.org/10.3390/vaccines11111732
Artigo de periodico
Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization (2023)
Usuda, Julia N ; Plaça, Desireé Rodrigues ; Fonseca, Dennyson Leandro Mathias da ; Marques, Alexandre H. C; Filgueiras, Igor Salerno ; Chaves, Victor Gabriel Bastos ; Adri, Anny Silva; Carvalho, Amanda Torrentes de ; Hirata, Mario Hiroyuki ; Freire, Paula Paccielli ; Catar, Rusan ; Miranda, Gustavo Cabral de ; Schimke, Lena F; Moll, Guido ; Marques, Otavio Cabral
Source: Frontiers in Immunology. Unidades: FCF, ICB, BIOTECNOLOGIA
Subjects: DENGUE, ARBOVÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
USUDA, Julia N et al. Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization. Frontiers in Immunology, v. 14, p. 1-16 art. 1243516, 2023Tradução . . Disponível em: https://dx.doi.org/10.3389/fimmu.2023.1243516. Acesso em: 05 nov. 2024.
APA
Usuda, J. N., Plaça, D. R., Fonseca, D. L. M. da, Marques, A. H. C., Filgueiras, I. S., Chaves, V. G. B., et al. (2023). Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization. Frontiers in Immunology, 14, 1-16 art. 1243516. doi:10.3389/fimmu.2023.1243516
NLM
Usuda JN, Plaça DR, Fonseca DLM da, Marques AHC, Filgueiras IS, Chaves VGB, Adri AS, Carvalho AT de, Hirata MH, Freire PP, Catar R, Miranda GC de, Schimke LF, Moll G, Marques OC. Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization [Internet]. Frontiers in Immunology. 2023 ; 14 1-16 art. 1243516.[citado 2024 nov. 05 ] Available from: https://dx.doi.org/10.3389/fimmu.2023.1243516
Vancouver
Usuda JN, Plaça DR, Fonseca DLM da, Marques AHC, Filgueiras IS, Chaves VGB, Adri AS, Carvalho AT de, Hirata MH, Freire PP, Catar R, Miranda GC de, Schimke LF, Moll G, Marques OC. Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization [Internet]. Frontiers in Immunology. 2023 ; 14 1-16 art. 1243516.[citado 2024 nov. 05 ] Available from: https://dx.doi.org/10.3389/fimmu.2023.1243516
Artigo de periodico
Past, present, and future of naturally occurring antimicrobials related to snake venoms (2023)
Oguiura, Nancy ; Sanches, Leonardo ; Duarte , Priscila V; López, Marcos A. Sulca ; Machini, Maria Teresa
Source: Animals. Unidades: BIOTECNOLOGIA, IQ
Subjects: VENENOS, TOXINAS EM ANIMAL, COBRAS, IMUNIDADE, GENES, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OGUIURA, Nancy et al. Past, present, and future of naturally occurring antimicrobials related to snake venoms. Animals, v. 13, p. 1-35 art. 744, 2023Tradução . . Disponível em: https://doi.org/10.3390/ani13040744. Acesso em: 05 nov. 2024.
APA
Oguiura, N., Sanches, L., Duarte , P. V., López, M. A. S., & Machini, M. T. (2023). Past, present, and future of naturally occurring antimicrobials related to snake venoms. Animals, 13, 1-35 art. 744. doi:10.3390/ani13040744
NLM
Oguiura N, Sanches L, Duarte PV, López MAS, Machini MT. Past, present, and future of naturally occurring antimicrobials related to snake venoms [Internet]. Animals. 2023 ; 13 1-35 art. 744.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/ani13040744
Vancouver
Oguiura N, Sanches L, Duarte PV, López MAS, Machini MT. Past, present, and future of naturally occurring antimicrobials related to snake venoms [Internet]. Animals. 2023 ; 13 1-35 art. 744.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/ani13040744
Artigo de periodico
Integrated control strategies for dengue, Zika, and Chikungunya virus infections (2023)
Cortês, Nelson de Angelis ; Lira, Aline Aparecida de Lima ; Syed, Wasim Aluísio Prates ; Silva, Jaqueline Dinis Queiroz; Vuitika, Larissa ; Miranda, William Cabral de ; Durães-Carvalho, Ricardo ; Cabral-Marques, Otavio ; Cabral-Miranda, Gustavo ; Balan, Andrea
Source: Frontiers in Immunology. Unidades: FM, ICB, BIOTECNOLOGIA, FCF
Subjects: MICROBIOLOGIA, ANTIVIRAIS, ARBOVÍRUS, INFECÇÕES POR ARBOVIRUS, VÍRUS CHIKUNGUNYA, VÍRUS DA DENGUE, ZIKA VÍRUS, VETORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTÊS, Nelson de Angelis et al. Integrated control strategies for dengue, Zika, and Chikungunya virus infections. Frontiers in Immunology, v. 14, p. 13 , 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1281667. Acesso em: 05 nov. 2024.
APA
Cortês, N. de A., Lira, A. A. de L., Syed, W. A. P., Silva, J. D. Q., Vuitika, L., Miranda, W. C. de, et al. (2023). Integrated control strategies for dengue, Zika, and Chikungunya virus infections. Frontiers in Immunology, 14, 13 . doi:10.3389/fimmu.2023.1281667
NLM
Cortês N de A, Lira AA de L, Syed WAP, Silva JDQ, Vuitika L, Miranda WC de, Durães-Carvalho R, Cabral-Marques O, Cabral-Miranda G, Balan A. Integrated control strategies for dengue, Zika, and Chikungunya virus infections [Internet]. Frontiers in Immunology. 2023 ; 14 13 .[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fimmu.2023.1281667
Vancouver
Cortês N de A, Lira AA de L, Syed WAP, Silva JDQ, Vuitika L, Miranda WC de, Durães-Carvalho R, Cabral-Marques O, Cabral-Miranda G, Balan A. Integrated control strategies for dengue, Zika, and Chikungunya virus infections [Internet]. Frontiers in Immunology. 2023 ; 14 13 .[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fimmu.2023.1281667
Artigo de periodico
Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice (2022)
Kajitani, Gustavo Satoru; Quayle, Carolina de Barros Reis ; Garcia, Camila Carrião Machado ; Fotoran, Wesley Luzetti ; Santos, Juliana F. R. dos; Horst, Gijsbertus T. J. van der ; Hoeijmakers, Jan H. J. ; Menck, Carlos Frederico Martins
Source: Frontiers in Immunology. Unidades: ICB, IB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, RADIAÇÃO ULTRAVIOLETA, REPARAÇÃO DE DNA, CÉLULAS MORTAS, NEOPLASIAS CUTÂNEAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAJITANI, Gustavo Satoru et al. Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice. Frontiers in Immunology, v. 13, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.800606. Acesso em: 05 nov. 2024.
APA
Kajitani, G. S., Quayle, C. de B. R., Garcia, C. C. M., Fotoran, W. L., Santos, J. F. R. dos, Horst, G. T. J. van der, et al. (2022). Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice. Frontiers in Immunology, 13, 1-10. doi:10.3389/fimmu.2022.800606
NLM
Kajitani GS, Quayle C de BR, Garcia CCM, Fotoran WL, Santos JFR dos, Horst GTJ van der, Hoeijmakers JHJ, Menck CFM. Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fimmu.2022.800606
Vancouver
Kajitani GS, Quayle C de BR, Garcia CCM, Fotoran WL, Santos JFR dos, Horst GTJ van der, Hoeijmakers JHJ, Menck CFM. Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fimmu.2022.800606
Artigo de periodico
Chikungunya virus E2 structural protein B-cell epitopes analysis (2022)
Silva, João Paulo da Cruz ; Cunha, Marielton dos Passos ; Pour, Shahab Zaki ; Hering, Vitor Renaux; Lima Neto, Daniel Ferreira de ; Zanotto, Paolo Marinho de Andrade
Source: Viruses. Unidades: BIOINFORMÁTICA, ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, EPITOPOS, VÍRUS CHIKUNGUNYA, VÍRUS DE RNA, ANTICORPOS, LINFÓCITOS B, PEPTÍDEOS, ELISA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, João Paulo da Cruz et al. Chikungunya virus E2 structural protein B-cell epitopes analysis. Viruses, v. 14, n. 8, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3390/v14081839. Acesso em: 05 nov. 2024.
APA
Silva, J. P. da C., Cunha, M. dos P., Pour, S. Z., Hering, V. R., Lima Neto, D. F. de, & Zanotto, P. M. de A. (2022). Chikungunya virus E2 structural protein B-cell epitopes analysis. Viruses, 14( 8), 1-16. doi:10.3390/v14081839
NLM
Silva JP da C, Cunha M dos P, Pour SZ, Hering VR, Lima Neto DF de, Zanotto PM de A. Chikungunya virus E2 structural protein B-cell epitopes analysis [Internet]. Viruses. 2022 ; 14( 8): 1-16.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/v14081839
Vancouver
Silva JP da C, Cunha M dos P, Pour SZ, Hering VR, Lima Neto DF de, Zanotto PM de A. Chikungunya virus E2 structural protein B-cell epitopes analysis [Internet]. Viruses. 2022 ; 14( 8): 1-16.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/v14081839
Artigo de periodico
Vaccines against emerging and neglected infectious diseases: an overview (2022)
Vuitika, Larissa ; Syed, Wasim Aluísio Prates ; Silva, Jaqueline Dinis Queiros; Crema, Karin Paola ; Oliveira, Nelson Côrtes de ; Lira, Aline Aparecida de lima ; Lima, Julia Beatriz Menuci ; Câmara, Niels Olsen Saraiva ; Schimke, Lena Friederike ; Marques, Otavio Cabral ; Sadraeian, Mohammad ; Chaves, Lorena C. S. ; Miranda, Gustavo Cabral de
Source: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Subjects: IMUNOLOGIA, VACINAS, DOENÇAS INFECCIOSAS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VUITIKA, Larissa et al. Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, v. 10, n. 9, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10091385. Acesso em: 05 nov. 2024.
APA
Vuitika, L., Syed, W. A. P., Silva, J. D. Q., Crema, K. P., Oliveira, N. C. de, Lira, A. A. de lima, et al. (2022). Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, 10( 9), 1-11. doi:10.3390/vaccines10091385
NLM
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/vaccines10091385
Vancouver
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/vaccines10091385
Artigo de periodico
Transgenic ‘Hamlin’ sweet orange expressing csd1 or d4e1 genes exhibits decreased susceptibility to citrus canker disease (2022)
Docema, Matheus Luís ; Moraes, Tatiana de Souza ; Attílio, Lísia Borges; Marques, João Paulo Rodrigues; Stipp, Liliane Cristina Liborio ; Harakava, Ricardo ; Freitas-Astúa, Juliana ; Belasque Junior, José ; Azevedo, Ricardo Antunes ; Gaziola, Salete Aparecida ; Mourão Filho, Francisco de Assis Alves
Source: Plant Cell, Tissue and Organ Culture (PCTOC). Unidades: FZEA, ESALQ, BIOTECNOLOGIA, CENA
Subjects: BACTÉRIAS FITOPATOGÊNICAS, CANCRO (DOENÇA DE PLANTA), EXPRESSÃO GÊNICA, LARANJA, MANEJO INTEGRADO, PLANTAS TRANSGÊNICAS, RESISTÊNCIA GENÉTICA VEGETAL, XANTHOMONAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOCEMA, Matheus Luís et al. Transgenic ‘Hamlin’ sweet orange expressing csd1 or d4e1 genes exhibits decreased susceptibility to citrus canker disease. Plant Cell, Tissue and Organ Culture (PCTOC), p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.1007/s11240-022-02420-3. Acesso em: 05 nov. 2024.
APA
Docema, M. L., Moraes, T. de S., Attílio, L. B., Marques, J. P. R., Stipp, L. C. L., Harakava, R., et al. (2022). Transgenic ‘Hamlin’ sweet orange expressing csd1 or d4e1 genes exhibits decreased susceptibility to citrus canker disease. Plant Cell, Tissue and Organ Culture (PCTOC), 1-19. doi:10.1007/s11240-022-02420-3
NLM
Docema ML, Moraes T de S, Attílio LB, Marques JPR, Stipp LCL, Harakava R, Freitas-Astúa J, Belasque Junior J, Azevedo RA, Gaziola SA, Mourão Filho F de AA. Transgenic ‘Hamlin’ sweet orange expressing csd1 or d4e1 genes exhibits decreased susceptibility to citrus canker disease [Internet]. Plant Cell, Tissue and Organ Culture (PCTOC). 2022 ; 1-19.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s11240-022-02420-3
Vancouver
Docema ML, Moraes T de S, Attílio LB, Marques JPR, Stipp LCL, Harakava R, Freitas-Astúa J, Belasque Junior J, Azevedo RA, Gaziola SA, Mourão Filho F de AA. Transgenic ‘Hamlin’ sweet orange expressing csd1 or d4e1 genes exhibits decreased susceptibility to citrus canker disease [Internet]. Plant Cell, Tissue and Organ Culture (PCTOC). 2022 ; 1-19.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s11240-022-02420-3
Artigo de periodico
Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil (2022)
Santos, Robert Andreata ; Machado, Rafael Rahal Guaragna ; Alves, Rúbens Prince dos Santos ; Sales, Natiely Silva ; Soares, Camila Pereira ; Rodrigues, Karine Bitencourt ; Andrade, Juliana Bannwart ; Fock, Ricardo Ambrósio ; Margarido, Paulo Francisco Ramos ; Carvalho, Cristiane Rodrigues Guzzo ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza
Source: Frontiers in Cellular and Infection Microbiology. Unidades: HU, ICB, FCF, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, TESTES SOROLÓGICOS, TRIAGEM, SERVIÇOS DE SAÚDE, ESTUDOS RETROSPECTIVOS, ANTICORPOS, ELISA, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Robert Andreata et al. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, v. 12, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.787411. Acesso em: 05 nov. 2024.
APA
Santos, R. A., Machado, R. R. G., Alves, R. P. dos S., Sales, N. S., Soares, C. P., Rodrigues, K. B., et al. (2022). Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, 12, 1-8. doi:10.3389/fcimb.2022.787411
NLM
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Vancouver
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Artigo de periodico
Nanoengineering of catalysts for enhanced hydrogen production (2022)
Fiorio, Jhonatan Luiz ; Gothe, Maitê Lippel ; Kohlrausch, Emerson Cristofer ; Zardo, Maria Luísa ; Tanaka, Auro Atsushi ; Lima, Roberto Batista de; Silva, Anderson Gabriel Marques da; Garcia, Marco Aurélio Suller ; Vidinha, Pedro ; Machado, Giovanna
Source: Hydrogen. Unidades: IQ, BIOTECNOLOGIA
Subjects: HIDROGÊNIO, NANOTECNOLOGIA, NANOPARTÍCULAS, MATERIAIS COMPÓSITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIORIO, Jhonatan Luiz et al. Nanoengineering of catalysts for enhanced hydrogen production. Hydrogen, v. 3, n. 2, p. 218-254, 2022Tradução . . Disponível em: https://doi.org/10.3390/hydrogen3020014. Acesso em: 05 nov. 2024.
APA
Fiorio, J. L., Gothe, M. L., Kohlrausch, E. C., Zardo, M. L., Tanaka, A. A., Lima, R. B. de, et al. (2022). Nanoengineering of catalysts for enhanced hydrogen production. Hydrogen, 3( 2), 218-254. doi:10.3390/hydrogen3020014
NLM
Fiorio JL, Gothe ML, Kohlrausch EC, Zardo ML, Tanaka AA, Lima RB de, Silva AGM da, Garcia MAS, Vidinha P, Machado G. Nanoengineering of catalysts for enhanced hydrogen production [Internet]. Hydrogen. 2022 ; 3( 2): 218-254.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/hydrogen3020014
Vancouver
Fiorio JL, Gothe ML, Kohlrausch EC, Zardo ML, Tanaka AA, Lima RB de, Silva AGM da, Garcia MAS, Vidinha P, Machado G. Nanoengineering of catalysts for enhanced hydrogen production [Internet]. Hydrogen. 2022 ; 3( 2): 218-254.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/hydrogen3020014
Artigo de periodico
Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states (2022)
Schimke, Lena Friederike ; Marques, Alexandre Henrique Carvalho ; Baiocchi, Gabriela Crispim ; Prado, Caroline Aliane de Souza ; Fonseca, Dennyson Leandro Mathias da; Freire, Paula Paccielli ; Plaça, Desirée Rodrigues ; Filgueiras, Igor Salerno ; Salgado, Ranieri Coelho ; Marques, Gabriel Jansen; Oliveira, Antonio Edson Rocha ; Peron, Jean Pierre Schatzmann ; Miranda, Gustavo Cabral; Barbuto, José Alexandre Marzagão ; Câmara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Ochs, Hans D.; Condino Neto, Antonio ; Nakaya, Helder Takashi Imoto ; Overmyer, Katherine A.; Coon, Joshua J.
Source: Cells. Unidades: ICB, BIOTECNOLOGIA, FCF, EACH
Subjects: IMUNOLOGIA, COVID-19, EXPRESSÃO GÊNICA, TRANSCRIÇÃO GÊNICA, NEUTRÓFILOS, COVID-19, INFLAMAÇÃO, CITOCINAS, QUIMIOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHIMKE, Lena Friederike et al. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells, v. 11, n. 5, p. 1-24, 2022Tradução . . Disponível em: https://doi.org/10.3390/cells11050847. Acesso em: 05 nov. 2024.
APA
Schimke, L. F., Marques, A. H. C., Baiocchi, G. C., Prado, C. A. de S., Fonseca, D. L. M. da, Freire, P. P., et al. (2022). Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells, 11( 5), 1-24. doi:10.3390/cells11050847
NLM
Schimke LF, Marques AHC, Baiocchi GC, Prado CA de S, Fonseca DLM da, Freire PP, Plaça DR, Filgueiras IS, Salgado RC, Marques GJ, Oliveira AER, Peron JPS, Miranda GC, Barbuto JAM, Câmara NOS, Calich VLG, Ochs HD, Condino Neto A, Nakaya HTI, Overmyer KA, Coon JJ. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states [Internet]. Cells. 2022 ; 11( 5): 1-24.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/cells11050847
Vancouver
Schimke LF, Marques AHC, Baiocchi GC, Prado CA de S, Fonseca DLM da, Freire PP, Plaça DR, Filgueiras IS, Salgado RC, Marques GJ, Oliveira AER, Peron JPS, Miranda GC, Barbuto JAM, Câmara NOS, Calich VLG, Ochs HD, Condino Neto A, Nakaya HTI, Overmyer KA, Coon JJ. Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states [Internet]. Cells. 2022 ; 11( 5): 1-24.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/cells11050847
Artigo de periodico
Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy (2022)
Pagni, Roberta Liberato ; Souza, Patrícia da Cruz; Pegoraro, Rafael; Ribeiro, Bruna Felício Milazzotto Maldonado Porchia ; Silva, Jamile Ramos da ; Aps, Luana Raposo de Melo Moraes; Silva, Mariângela de Oliveira ; Rodrigues, Karine Bitencourt ; Sales, Natiely Silva ; Ferreira, Luís Carlos de Souza ; Moreno, Ana Carolina Ramos
Source: Frontiers in Immunology. Unidades: ICB, FM, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, INFECÇÕES POR PAPILLOMAVIRUS, NEOPLASIAS DO COLO UTERINO, INTERLEUCINA 6, IMUNOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, VACINAS VIRAIS, HPV, CAMUNDONGOS, ENZIMAS OXIRREDUTORAS, ATIVAÇÃO ENZIMÁTICA, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAGNI, Roberta Liberato et al. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy. Frontiers in Immunology, v. 13, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1005937. Acesso em: 05 nov. 2024.
APA
Pagni, R. L., Souza, P. da C., Pegoraro, R., Ribeiro, B. F. M. M. P., Silva, J. R. da, Aps, L. R. de M. M., et al. (2022). Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.1005937
NLM
Pagni RL, Souza P da C, Pegoraro R, Ribeiro BFMMP, Silva JR da, Aps LR de MM, Silva M de O, Rodrigues KB, Sales NS, Ferreira LC de S, Moreno ACR. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fimmu.2022.1005937
Vancouver
Pagni RL, Souza P da C, Pegoraro R, Ribeiro BFMMP, Silva JR da, Aps LR de MM, Silva M de O, Rodrigues KB, Sales NS, Ferreira LC de S, Moreno ACR. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3389/fimmu.2022.1005937
Artigo de periodico
Algal-derived halogenated Sesquiterpenes from Laurencia dendroidea as lead compounds in schistosomiasis environmental control (2022)
Santos, Guilherme Senna dos; Miyasato, Patricia Aoki; Stein, Erika Mattos ; Colepicolo, Pio ; Wright, Anthony D; Pereira, Carlos Alberto de Bragança ; Falkenberg, Miriam; Nakano, Eliana
Source: Marine Drugs. Unidades: BIOTECNOLOGIA, IQ, IME
Subjects: SESQUITERPENOS, ALGAS, CHUMBO, ESQUISTOSSOMOSE, PRODUTOS NATURAIS, TERPENOS, SCHISTOSOMA MANSONI, LARVICIDAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Guilherme Senna dos et al. Algal-derived halogenated Sesquiterpenes from Laurencia dendroidea as lead compounds in schistosomiasis environmental control. Marine Drugs, v. 20, p. 1-10 art. 111, 2022Tradução . . Disponível em: https://doi.org/10.3390/md20020111. Acesso em: 05 nov. 2024.
APA
Santos, G. S. dos, Miyasato, P. A., Stein, E. M., Colepicolo, P., Wright, A. D., Pereira, C. A. de B., et al. (2022). Algal-derived halogenated Sesquiterpenes from Laurencia dendroidea as lead compounds in schistosomiasis environmental control. Marine Drugs, 20, 1-10 art. 111. doi:10.3390/md20020111
NLM
Santos GS dos, Miyasato PA, Stein EM, Colepicolo P, Wright AD, Pereira CA de B, Falkenberg M, Nakano E. Algal-derived halogenated Sesquiterpenes from Laurencia dendroidea as lead compounds in schistosomiasis environmental control [Internet]. Marine Drugs. 2022 ; 20 1-10 art. 111.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/md20020111
Vancouver
Santos GS dos, Miyasato PA, Stein EM, Colepicolo P, Wright AD, Pereira CA de B, Falkenberg M, Nakano E. Algal-derived halogenated Sesquiterpenes from Laurencia dendroidea as lead compounds in schistosomiasis environmental control [Internet]. Marine Drugs. 2022 ; 20 1-10 art. 111.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3390/md20020111

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration